Sickle Cell Disease study: EndeavorRx
Official title Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
ClinicalTrials.gov ID: NCT05099874
What this study is testing
- What it's testing
- The study wants to see if the game can be used easily, is liked by participants, and shows early signs of helping attention.
- Who it's for
- Children ages 8‑16 who have sickle cell disease and are receiving chronic blood‑transfusion therapy.
- What's involved
- Participants will play the game on a tablet for 25‑30 minutes each day, five days a week, for four weeks. They will also complete study visits and simple tests of attention.
- Time commitment
- The trial lasts about four weeks and includes a few clinic visits for assessments before and after the training period.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 16
You may be able to join if
- diagnosis of SCD
- ages 8-16 years
- maintained on monthly blood transfusions consistently for at least 3 months.
- patients will be proceed to the intervention phase only if they have a T-score \> 75th percentile for Omission Errors on the Conners' Continuous...
You likely can't join if
- estimated Intelligence Quotient \< 70
- motor, visual, or auditory impairment that prevents computer use
- known diagnosis of a mental health condition that precludes, or takes treatment precedence over, participation in cognitive training
- history of photosensitive seizures
- insufficient English fluency.
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.